Aemetis Inc (NASDAQ: AMTX)’s stock price has dropped by -6.14 in relation to previous closing price of 3.42. Nevertheless, the company has seen a loss of -4.18% in its stock price over the last five trading days. investorplace.com reported 2024-07-31 that Many cheap stocks under $10 are cheap for a good reason. Cash-burning biotechs, sketchy shell companies and overhyped fads with more sizzle than substance.
Is It Worth Investing in Aemetis Inc (NASDAQ: AMTX) Right Now?
Company’s 36-month beta value is 1.31.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AMTX is 40.46M, and currently, short sellers hold a 14.97% ratio of that floaft. The average trading volume of AMTX on August 01, 2024 was 571.43K shares.
AMTX’s Market Performance
AMTX’s stock has seen a -4.18% decrease for the week, with a 12.24% rise in the past month and a -17.69% fall in the past quarter. The volatility ratio for the week is 7.03%, and the volatility levels for the past 30 days are at 7.87% for Aemetis Inc The simple moving average for the past 20 days is -6.90% for AMTX’s stock, with a -20.45% simple moving average for the past 200 days.
Analysts’ Opinion of AMTX
Many brokerage firms have already submitted their reports for AMTX stocks, with UBS repeating the rating for AMTX by listing it as a “Buy.” The predicted price for AMTX in the upcoming period, according to UBS is $10.50 based on the research report published on August 16, 2023 of the previous year 2023.
Piper Sandler, on the other hand, stated in their research note that they expect to see AMTX reach a price target of $3. The rating they have provided for AMTX stocks is “Underweight” according to the report published on February 28th, 2023.
UBS gave a rating of “Neutral” to AMTX, setting the target price at $4.25 in the report published on December 14th of the previous year.
AMTX Trading at -3.77% from the 50-Day Moving Average
After a stumble in the market that brought AMTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.95% of loss for the given period.
Volatility was left at 7.87%, however, over the last 30 days, the volatility rate increased by 7.03%, as shares surge +8.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.62% lower at present.
During the last 5 trading sessions, AMTX fell by -4.18%, which changed the moving average for the period of 200-days by -25.17% in comparison to the 20-day moving average, which settled at $3.46. In addition, Aemetis Inc saw -38.74% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AMTX starting from BLOCK JOHN R, who sale 51,580 shares at the price of $3.49 back on May 23 ’24. After this action, BLOCK JOHN R now owns 14,001 shares of Aemetis Inc, valued at $180,014 using the latest closing price.
Boness Naomi Louise, the Director of Aemetis Inc, sale 15,000 shares at $5.65 during a trade that took place back on Sep 12 ’23, which means that Boness Naomi Louise is holding 16,441 shares at $84,694 based on the most recent closing price.
Stock Fundamentals for AMTX
Current profitability levels for the company are sitting at:
- -0.14 for the present operating margin
- 0.01 for the gross margin
The net margin for Aemetis Inc stands at -0.17. The total capital return value is set at -0.28.
Based on Aemetis Inc (AMTX), the company’s capital structure generated 2.21 points at debt to capital in total, while cash flow to debt ratio is standing at 0.03. The debt to equity ratio resting at -1.83. The interest coverage ratio of the stock is -0.66.
Currently, EBITDA for the company is -30.1 million with net debt to EBITDA at -13.41. When we switch over and look at the enterprise to sales, we see a ratio of 2.22. The receivables turnover for the company is 29.01for trailing twelve months and the total asset turnover is 1.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.28.
Conclusion
In a nutshell, Aemetis Inc (AMTX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
